The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

Weight loss medications like Ozempic and Wegovy have become increasingly popular over the last few years. For people struggling to lose weight through diet and exercise alone, these medications ...

Manchester United have made an official bid for Lecce star Patrick Dorgu, and the club’s president has revealed all on what was said in the meeting. The Red Devils are desperate to sign a left ...

A recent JAMA Network Open study investigated the factors associated with semaglutide initiation among obese adults without diabetes ... and cardiovascular disease prevention. Obesity, often ...

Opens in a new tab or window Patients treated with semaglutide ... biochemical and clinical outcomes after medical treatment for primary aldosteronism. (Lancet Diabetes & Endocrinology) Unadjusted ...

We do our best to be prepared for any hurdles we might face,” Rhonda Pacheco, group vice president of U.S. Diabetes and Obesity at Eli ... tirzepatide and semaglutide. It’s important to ...

Semaglutide (known ... since the prevalence of obesity in people with type 1 diabetes is increasing and is associated with the risk of cardiovascular disease and complications.

Ozempic is a brand-name, injectable semaglutide medication ... the treatment of type 2 diabetes in adults and is known to offer a reduced risk of certain major cardiovascular events including ...